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Introduction
Science does not have a magic formula for malaria, Plasmodium parasites are developing unacceptable levels of resistance and many insecticides are no longer useful against mosquitoes that transmit the disease. Years of vaccine research have produced few hopeful candidates and although scientists are redoubling the search, an effective vaccine is years away. 1 In response to this difficult situation, which in this study, we explored the pentose phosphate pathway of the malaria parasite Plasmodium falciparum (pf), in particular the Glucose-6-Phosphate Dehydrogenase enzyme (G6PD), in order to find a new potential therapeutic target and new alternative drugs. 2 
Methods
Was constructed the three dimensional structure of the enzyme pfG6PD using molecular homology modeling, with the MODELLER 3 program and human enzyme in the same structure as a mold.
From the structural change of a single residue of the active site between the two enzymes (Arg365-h/Asp575-pf), were proposed and complexed six selective inhibitors of the pfG6PD enzyme. Then studies of molecular dynamics (MD) using the method of molecular mechanics (MM) via the program AMBER 4 and binding free energy calculations using the SIE 5 method (solvated interaction energy). Time of Dynamic was 100 ns. 
Results and Discussion
Results showed that the proposed model is satisfactory, both structurally and energetically, the mean values of free energy (SIE) for hG6PD and pfG6PD were -7.46 and -7.71 kcal/mol, respectively, compatible with the literature,2 and site active well maintained with RMSD never exceeding 3 Å for pfG6PD. The SIE results presented next to the values found in G6P-pfG6PD complex, with values below -6kcal/mol for the proposed inhibitors LIG3 and LIG6, values close to those found in the interaction of the enzyme with G6
Conclusions
In this study was constructed the 3D structure of Glucose-6-Phosphate Dehydrogenase enzyme of the plasmodium falciparum pfG6PD, that presented a significantly mutation in one residue in the active site, compared with the similar human enzyme. Were proposed six ligands for inhibit the pfG6PD enzyme. The best ligands were LIG 3 and 6, based with SIE method. The mutation of this single residue found in active site of pfG6PD can open a new path in search of the Plasmodium falciparum selective inhibitors and drug candidates against malaria. These binders are being synthesized and applied in studies of biological assay in vitro to confirm the possibility of inhibition, results will be presented in a next opportunity.
